Marilyn S. Hamilton
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Marilyn S. Hamilton has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
Angela F. Nickell
The Children's Mercy Hospital, Kansas City, Missouri
1 shared publicationAngela Nickell
Virology Laboratory Department of Pathology
1 shared publicationCraig D. Shimasaki
ZymeTx, Inc., Oklahoma City, Oklahoma
1 shared publicationDavid Abel
Virology Laboratory Department of Pathology
1 shared publicationDavid M. Abel
The Children's Mercy Hospital, Kansas City, Missouri
1 shared publicationDeb Rivera
Department of Occupational Health, Children's Mercy Hospitals and Clinics, Kansas City, MO
1 shared publication
Latest Publications
- Open Access
- 1 August 2014
- Published by Oxford University Press (OUP) in Laboratory Medicine
- Vol. 45 (3) , 207-210
QuantiFERON-TB Gold In-Tube Testing for Tuberculosis in Healthcare Professionals
Objective:. To assess the performance of the QuantiFERON-TB Gold in-tube (QFT-GIT) assay for tuberculosis (TB) screening using a convenience sample fro
- 1 August 2014
- Published by Oxford University Press (OUP) in Laboratory Medicine
- Vol. 45 (3) , 207-210
Open AccessQuantiFERON-TB Gold In-Tube Testing for Tuberculosis in Healthcare Professionals
Objective:. To assess the performance of the QuantiFERON-TB Gold in-tube (QFT-GIT) assay for tuberculosis (TB) screening using a convenience sample fro
- 17 February 2005
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 352 (7) , 731
Pump Priming in Heart Surgery in Infants
Mou and associates (Oct. 14 issue)1 report that the use of fresh whole blood for pump priming in cardiopulmonary bypass surgery in infants had no advantage over the use of reconstituted whole blood (a combination of red cells and fresh-frozen plasma). Indeed, priming with fresh whole blood was associated with an increased time in the intensive care unit and fluid overload. Since products from two donors were required to prepare reconstituted whole blood, the use of fresh whole blood reduced donor exposure. The authors suggest the extra exposure associated with reconstituted whole blood could be eliminated with the use of products from a single donor.
- 17 February 2005
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 352 (7) , 731
Pump Priming in Heart Surgery in Infants
Mou and associates (Oct. 14 issue)1 report that the use of fresh whole blood for pump priming in cardiopulmonary bypass surgery in infants had no advantage over the use of reconstituted whole blood (a combination of red cells and fresh-frozen plasma). Indeed, priming with fresh whole blood was associated with an increased time in the intensive care unit and fluid overload. Since products from two donors were required to prepare reconstituted whole blood, the use of fresh whole blood reduced donor exposure. The authors suggest the extra exposure associated with reconstituted whole blood could be eliminated with the use of products from a single donor.
- Open Access
- 1 November 2002
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 40 (11) , 4393
High Frequency of Competitive Inhibition in the Roche Cobas AMPLICOR Multiplex PCR for Chlamydia trachomatis and Neisseria gonorrhoeae
The term multiplex PCR refers to simultaneous amplification of more than one target in a single PCR. This method has some advantages but presents the possibility of competition between multiple targets for a finite number of reagents, which may invalidate the assay. The Roche Cobas AMPLICOR
- 1 November 2002
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 40 (11) , 4393
Open AccessHigh Frequency of Competitive Inhibition in the Roche Cobas AMPLICOR Multiplex PCR for Chlamydia trachomatis and Neisseria gonorrhoeae
The term multiplex PCR refers to simultaneous amplification of more than one target in a single PCR. This method has some advantages but presents the possibility of competition between multiple targets for a finite number of reagents, which may invalidate the assay. The Roche Cobas AMPLICOR
- Open Access
- 1 July 2002
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 40 (7) , 2331-2334
Clinical Evaluation of the ZstatFlu-II Test: a Chemiluminescent Rapid Diagnostic Test for Influenza Virus
Exploiting the high sensitivity of the chemiluminescence phenomenon, an accurate and sensitive point-of-care test, called the ZstatFlu-II test (ZymeTx, Inc., Oklahoma City, Okla.), was developed to detect influenza virus infections. The ZstatFlu-II test takes 20 min and requires approximately 2 min of “hands-on” time for operational steps. The ZstatFlu-II test does not distinguish between infections with influenza virus types A and B. ZstatFlu-II test results are printed on Polaroid High-Speed Detector Film, allowing test results to be archived. A prototype version of the ZstatFlu-II test was evaluated during the 2000-to-2001 flu season with 300 nasal aspirate specimens from children at a pediatric hospital. Compared to culture, the ZstatFlu-II test had 88% sensitivity and 92% specificity. The Directigen test had a sensitivity of 75% and a specificity of 93%. The sensitivity of the ZstatFlu-II test was significantly higher than that of the Directigen test ( P < 0.0574).
- 1 July 2002
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 40 (7) , 2331-2334
Open AccessClinical Evaluation of the ZstatFlu-II Test: a Chemiluminescent Rapid Diagnostic Test for Influenza Virus
Exploiting the high sensitivity of the chemiluminescence phenomenon, an accurate and sensitive point-of-care test, called the ZstatFlu-II test (ZymeTx, Inc., Oklahoma City, Okla.), was developed to detect influenza virus infections. The ZstatFlu-II test takes 20 min and requires approximately 2 min of “hands-on” time for operational steps. The ZstatFlu-II test does not distinguish between infections with influenza virus types A and B. ZstatFlu-II test results are printed on Polaroid High-Speed Detector Film, allowing test results to be archived. A prototype version of the ZstatFlu-II test was evaluated during the 2000-to-2001 flu season with 300 nasal aspirate specimens from children at a pediatric hospital. Compared to culture, the ZstatFlu-II test had 88% sensitivity and 92% specificity. The Directigen test had a sensitivity of 75% and a specificity of 93%. The sensitivity of the ZstatFlu-II test was significantly higher than that of the Directigen test ( P < 0.0574).